Membranous Nephropathy Often Recurs After Kidney Transplantation
Effective therapy of post-transplant membranous nephropathy may improve outcomes.
Effective therapy of post-transplant membranous nephropathy may improve outcomes.
The current US Kidney Allocation System (KAS) may disadvantage waitlist candidates already receiving dialysis, according to investigators.
In a study, aviremic recipients of HCV-positive and HCV-negative deceased donor kidneys had similar 12-month transplant outcomes.
A growing body of research supports harvesting and transplanting of donor acute kidney injury kidneys.
The increased death risk associated with type 2 diabetes in kidney transplant recipients does not vary significantly by body mass index, according to investigators.
Study findings “have implications for development of SOT-specific approaches for risk stratification that may be applied to patient evaluation and triage,” according to investigators.
Performing dual deceased donor kidney transplantations may maximize use of suboptimal kidneys, according to investigators.
Monoclonal antibody therapy improves survival and reduces hospitalization risk among kidney transplant recipients with COVID-19, a study found.
The clinical usefulness of kidney graft protocol biopsies in stable low-risk patients has been debated.
Recent organ allocation changes have increased travel and subsequent cold ischemia times of kidney allografts.